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ABSTRACT 
Objectives: Stiff Skin Syndrome (SSS) is a rare scleroderma-like syndrome of unknown 
etiology. A 16-year-old boy presented with thoracic and abdominal asymmetry, and “orange 
peel” cutaneous lesions, with fibrotic stone-hard indurations at the buttocks, thighs, and arms 
leading to secondary joint contractures of the extremities. Our aim was to analyse the 
expression of extracellular matrix (ECM) molecules and pro-fibrotic cytokines in the dermis 
and epidermis of SSS. 
Methods: The diagnosis of SSS was confirmed by clinical and histopathological examination. 
Col1A2, fibronectin-1, thrombospondin-1, TGF-, CTGF, IL-6, IL-1-, endothelin-1, FGFR-
3, and MCP-1 expression was analysed in SSS and age- and sex-matched healthy control skin 
by Real-Time PCR. VEGF expression was also studied.  
Results: Histopathological examination showed flattened dermal papillae, a scarce presence 
of sub-epidermal microvessels and mild dermal fibrosis, but no inflammatory infiltrates. In 
the SSS dermis, the expression of IL-1, IL-6 and MCP-1 was low, whereas VEGF was 
intensively expressed. No differences were observed for TGF-, CTGF and endothelin-1. In 
contrast, col1A2, fibronectin-1 and thrombospondin-1 were overexpressed in the SSS dermis.  
Conclusion: In our SSS patient, an overexpression of ECM proteins was detected, whereas no 
inflammatory infiltrates or pro-fibrotic cytokines upregulation were found. The data suggest 
that fibrosis in SSS might be independent from inflammation. 
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INTRODUCTION 
Stiff Skin Syndrome (SSS) is clinically characterised by stone-hard skin, leading to a 
secondary limitation of joint mobility. First manifestations of SSS are usually observed 
between birth and early childhood [1], and the disease progresses until the skin of the entire 
body becomes fibrotic with subsequent growth retardation and joint contractures. Skin 
fibrosis can also lead to decreased costo-vertebral joint mobility with restrictive changes of 
lung function [1]. 
SSS was first described in 1968 in a boy with joint contractures and skin changes resembling 
scleroderma [1] and, in 1971, in four patients showing skin hardening and secondary 
limitation of joint mobility [2]. Until now, about 30 SSS patients have been described in the 
literature, with few familiar cases [2-4]. The pathogenesis of SSS remains unknown. Initially, 
an abnormal mucopolysaccharide metabolism limited to the skin, in absence of 
mucopolysacchariduria, has been suggested [2]. Cutaneous lesions in SSS were attributed to 
deposits of acid mucopolysaccharides localized within collagen fibres in the dermis and 
hypodermis [1,2,5-7]. Recently, the most relevant modifications were localized in the fascia, 
which was thickened by a hyalinized collagenous tissue [3-6,9]. In skin fibroblasts, collagen 
synthesis was up-regulated as shown by increased activity of prolylhydroxylase and 
lysylhydroxylase [9].  
The aim of our study was to investigate, in a young boy with SSS, the cutaneous 
histopathology and the expression of extracellular matrix (ECM) molecules and pro-fibrotic  
cytokines in order to provide new insights into the pathogenesis of this rare disease.   
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CASE REPORT   
A 16-year-old boy, born from healthy unrelated parents, was referred to the Division of 
Rheumatology of the University of Florence. No-one in the family was affected by a similar 
or fibrosing disease. Medical history revealed that, on the second day after delivery, he had 
developed severe icterus requiring ex-sanguinis-transfusion due to maternal-fetal 
incompatibility (ABO anti-A). A reduced height-weight growth during the first year was 
observed but blood tests including serum creatinine, transaminases, glucose, and complete 
blood cell count were within normal limits. Thyroid function was also normal and screening 
for celiac disease, arginine-stimulated growth hormone (GH) dosage and metabolic tests were 
negative.  
At one year of age, the baby developed thoracic and abdominal asymmetry, and “orange peel“ 
cutaneous lesions mimicking eosinophilic fascitis, with induration of the buttocks, thighs, and 
arms. Since then, the skin and the underlying tissues, progressively hardened leading to a 
reduced extension of the right elbow and both legs.  
At 4 years of age, a biopsy from the right thigh including cutaneous, subcutaneous layers, and 
muscle fascia, was taken and showed dense fibrous thickened fascia, three to four times the 
normal size with increased deposition of collagen. A mild fibrosis of the deep portion of 
dermis retinacula and mild interstitial accumulation of mucopolysaccharides without 
inflammatory infiltrates or vascular changes were observed. Antinuclear antibodies (ANA), 
extractable nuclear antigen (ENA) antibodies and anti-centromere antibodies (ACA) were 
negative and complement fractions (C3 and C4) were normal. Esophageal and chest X-rays, 
nailfold capillaroscopy, ophtalmological and psychological evaluations were negative. Hand 
X-rays, at 8 years, showed a skeletal age of 4 years.  
When the patient was brought to our attention at an age of 16 years the most relevant sign was 
the stone-hard induration of buttocks and thighs (Figure 1A). The patient was not receiving 
any pharmacological treatment. Raynaud’s phenomenon, sclerodactily, fingertip ulcers and 
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dysphagia were not observed. The following tests were normal: complete blood count, kidney 
and liver functional tests, erythrocyte sedimentation rate (Westergren), C-reactive protein, C3 
and C4, serum lysozyme, serum electrophoresis, serum hormonal estimations (pubertal 
values), routine urine analysis, abdominal ultrasound and echocardiography. Chest X-ray 
showed rib cage dysmorphism. Pulmonary function tests revealed a mild reduction of force 
vital capacity (FVC) (2.61 vs 3.93 predicted). Osteocalcin was increased to 93.3 ng/ml 
(normal range 11.1-32.2 ng/ml). Dual X-ray of spinal column at the lumbar lever showed 
significant reduction of bone mass with osteoporosis (T score L4 -2.74). No calcifications of 
soft periarticular tissues were observed. Anti-smooth muscle, anti-microsomal, anti-
mitochondrial, anti-nuclear, anti-nDNA, ENA, anti-centromere, anti-phospholipid, anti-
thyroid (anti-TG, anti-TSH, anti-TPO), anti-gastric mucosa antibodies were negative. Nailfold 
videocapillaroscopic examination did not reveal any significant alterations. 
Despite generalized limitation of joint mobility, there was no evidence of joint inflammation. 
The child showed difficulty walking due to stiffness of the right lower limb. The clinical 
features fulfilled the criteria for SSS proposed by Kikuchi [1]: stiff skin, limitation of joint 
mobility without visceral involvement, and no increased amount of mucopolysacchariduria. 
Hypertrichosis, skin atrophy, dental abnormalities, bone hypoplasia and knuckle pads were 
not detected in our patient.  
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MATERIALS AND METHODS 
 
Sample collection 
Full-thickness biopsies, approximately 3 x 0.5 cm, were obtained from the clinically involved 
skin of the right femoral region of the SSS patient. Skin biopsies were obtained also from the 
same anatomical region of three age- and sex-matched healthy control subjects who 
underwent surgery for traumatic lesions. Each biopsy was cut into two samples and processed 
for histological analysis and Real-Time PCR. Biopsies were taken after informed consent 
from parents and approval by the Institutional Review Board was obtained. 
 
Histopathological analysis 
For histopathological analysis, the specimens were fixed in 10% buffered formalin and 
routinely processed for paraffin embedding. Sections (5 m thick) were processed for 
haematoxylin and eosin (H&E), Masson’s trichrome, and alcian blue stainings (Bio-Optica, 
Milan, Italy). The stained sections were examined under a light microscope (Eclipse E400; 
Nikon, Tokyo, Japan) and photographed with a digital camera (Coolpix 2500; Nikon). 
 
Immunohistochemistry 
Sections were de-waxed and heated in EDTA buffer (pH 8.0) for antigen retrieval. After 
blocking endogenous peroxidase activity and non-specific site binding, the sections were 
incubated with a mouse monoclonal antibody against the panendothelial marker von 
Willebrand factor (vWF; 1:50 dilution; Novocastra Laboratories, Newcastle, UK). The 
immunoreactivity was detected using biotinylated secondary antibodies and avidin-biotin-
peroxidase complex (UltraVision Detection System; LabVision Corporation, Fremont, CA), 
followed by color development using 3,3’-diaminobenzidine tetrahydrochloride (Vector, 
Burlingame, CA) as chromogen. Sections were lightly counterstained with Mayer’s 
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haematoxylin, and finally the slides were mounted with Aquatex mounting medium (Merck, 
Darmstadt, Germany). Normal isotype-matched IgG (Sigma, St. Louis, MO) were used at the 
same concentration to replace the primary antibody, as a negative staining control. The 
stained sections were examined under a light microscope (Eclipse E400). Three fields (x40 
magnification) from two random sections of each biopsy were analyzed by a blinded 
observer. In the examined fields we performed a semiquantitative analysis of vWF-positive 
blood vessels, considering the distinct areas such as papillary dermis and reticular dermis. The 
score was defined as follows: +++ = plenty of vessels; ++ = moderate presence of vessels; + = 
few vessels; +/- = very few vessels; - = hardly any vessels, as described elsewhere [10].  
 
Quantitative Real-Time PCR 
In each biopsy, the epidermis was separated from the dermis for better homogenisation of the 
tissue samples and better comparability of the gene expression. For Real-Time PCR, total 
RNA was reverse transcribed into cDNA with Random Hexamers (Applied Biosystems, 
Rotkreuz, Switzerland). For quantification of mRNA, SYBR Green real-time PCR 
(endothelin-1, CTGF, IL-6, IL-1, FGFR-3, TGF-, col1A2, fibronectin-1 and 
thrombospondin-1) or TaqMan real-time PCR (MCP-1 and VEGF) was performed using the 
ABI Prism 7700 Sequence Detection System (Applied Biosystems). Specific primer pairs for 
each gene were designed with the Primer Express software (Applied Biosystems) as described 
elsewhere [11-15]. Unspecific signals caused by primer dimers or genomic DNA were 
excluded by dissociation curve analysis,  no template controls and samples without enzyme in 
the reverse transcription (non-RT-controls). A pre-developed β-actin assay (Applied 
Biosystems) was used as an endogenous control to normalize for the amounts of loaded 
cDNA. Differences were calculated with the threshold cycle (Ct) and the comparative Ct 
method for relative quantification. All measurements were performed in duplicate. 
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RESULTS 
 
Analysis of Fibrosis 
a)  Histopathological findings. The SSS skin showed flattened dermal papillae, 
and absence of sebaceous glands (Figure 1D) as compared with control skin 
(Figure 1C). In the dermis, tightly packed and irregularly distributed collagen 
bundles were observed with mild fibrosis, as shown by Masson’s trichrome 
staining (Figures 1E,F). Alcian blue staining was negative indicating the 
absence of mucopolysaccharide deposits between collagen bundles (Figure 
1B). 
b) Quantitative Real-Time PCR. In the dermis, an overexpression of col1A2, 
fibronectin, and thrombospondin-1 was observed, while in the epidermis none 
of these molecules was different from controls. Interestingly, no difference was 
detected in the expression of pro-fibrotic mediators (TGF-, endothelin-1 and 
CTGF) both in the epidermis and in the dermis (Table 1).  
 
Analysis of Microvessels 
a)  Histopathological findings. A loss of sub-epidermal microvessels (+) (Figures 
1G,H) was detected when compared to healthy skin, where microvessels are 
largely present (+++). In the reticular dermis a regular distribution and 
presence of blood vessels were observed (+++). 
b) Quantitative Real-Time PCR. In the dermis, VEGF was  increased in respect 
to control, while in the epidermis did not show any difference (Table 1). 
 
  Analysis of Inflammation 
a) Histopathological findings. No inflammatory infiltrates were detected in the 
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SSS dermis (Figure 1D).  
b) Quantitative Real-Time PCR. This analysis showed a different pattern 
between epidermis and dermis as IL-6, IL-1, FGFR-3, and MCP-1 were 
normally expressed in the epidermis, but down-regulated in the dermis (Table 
1).  
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DISCUSSION   
In the SSS dermis, the present study clearly showed an increase of fibrotic molecules 
(col1A2, fibronectin-1, thrombospondin-1) and the presence of irregularly distributed 
collagen bundles, flattening of dermal papillae and absence of sebaceous glands.  
Inflammatory mediators (IL-6, IL-1 FGFR-3, and MCP-1) were down-regulated in 
agreement with the absence of dermal inflammatory infiltrates. No differences in pro-fibrotic 
cytokines (TGF-, endothelin-1 and CTGF) were detected. In a previous work, circulating 
levels of proinflammatory cytokines (IL-6, TNF- and TGF-2), were found to be increased, 
whereas collagen production and DNA biosynthesis were normal [16]. These differences to 
our findings might be explained by the different methodological approach. In fact, assessment 
of these factors in the skin might be more relevant for the pathogenesis of the disease, as 
serum circulating levels are influenced by a large number of confounding factors. However, 
different disease stages might also account for controversial results. 
Up to date, about 30 cases of SSS have been described in the literature, but the pathogenesis 
remains still unknown. Usually, SSS is a diagnosis of exclusion, with a distinctive clinical 
presentation but no pathognomonic laboratory or pathological findings. The clinical 
differential diagnosis of stone-hard and thickened skin areas includes systemic sclerosis, 
scleredema, eosinophilic fasciitis, and scleromyxedema. The appearance of the disease in 
early childhood, the limitation of joint mobility, the proximal rather than a distal stiffness and 
the absence of organ involvement are the main clinical findings that differentiate SSS from 
systemic sclerosis [7,17]. Moreover, microvascular abnormalities, Raynaud’s phenomenon 
and autoantibodies were absent in SSS [18]. However, in our SSS patient, a loss of 
microvessels was clearly evident at the dermal-epidermal junction and in the papillary dermis, 
despite the overexpression of VEGF found in the dermis. 
SSS is a nonprogressive cutaneous disease and involves mostly the buttocks, the trunk, and 
thighs and does not show increased deposition of acid-mucopolysaccharides in the dermis 
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[16]. In agreement with other authors [16], our data did not show mucopolysaccharide 
deposits in the dermis. However, Geng et al [18] reported mild deposits of 
mucopolysaccharides between the collagen bundles throughout the dermis, hypothesising that 
SSS could be a localized form of mucopolysaccharidosis [2]. Notably, our patient had no 
exposure to chemical substances or drugs that have been implicated in the pathogenesis of 
pseudoscleroderma [19].  
The similarity between SSS and the alterations in collagen metabolism has been put forward 
in the model of the tight-skin mouse (Tsk-1) [5]. However, the literature remains controversial 
about the collagen production, as cultured fibroblasts of SSS or of Tsk-1 mouse were normal 
[5], but also revealed an abnormal production of collagen [9]. Our data clearly support the 
concept of an increased collagen and ECM production in the dermis as shown by quantitative 
Real-Time PCR. Richard et al. [16] proposed that a primary fibroblast defect or a fascial 
abnormality needs to be ruled out in this disease. Recently, Liu et al. [4] found areas of fascial 
sclerosis or increased fibroblast cellularity with thickened and sclerotic collagen bundles 
without associated inflammation. In our case, pro-inflammatory mediators such as IL-1and 
IL-6 involved in the regulation of dermal fibrosis, were down-regulated in the dermis, 
suggesting that fibrosis in SSS might be independent from an inflammatory process.  
In conclusion, our results suggest that the fibrotic process in SSS might be independent from 
local inflammation. However, it should be considered that our observations were performed 
on an SSS patient with longstanding disease, and therefore need to be confirmed in early 
disease stages. If these findings are confirmed in larger sample numbers, they have direct 
implications on therapeutic approaches in these patients, as unspecific immunosuppressive 
treatments are unlikely to be successful in these patients. Future investigations should focus 
on the dermis, and in particular on ECM components such as collagen fibres and microfibril 
metabolism. Further studies are warranted to clarify, at different disease stages, the factors 
involved in the development of dermal fibrosis in SSS.  
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 Rheumatology key messages:  
 In our SSS case, ECM proteins were overexpressed, whereas no inflammatory infiltrates 
or pro-fibrotic cytokines upregulation were found. 
 Fibrosis in SSS might be independent from local inflammation. 
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FIGURE LEGEND 
 
Figure 1. A: At the age of 16-year-old, the most relevant sign was the stone-hard skin 
induration of only buttocks and thighs. B: Negative alcian blue staining indicates the 
absence of mucopolysaccharide deposits between collagen bundles in SSS dermis 
(original magnification x40). C,D: H&E staining of control (C) and SSS (D) skin from 
the right femoral region (original magnification x20). No inflammatory infiltrates are 
present in SSS dermis (D). E,F: Masson’s trichrome staining of control (E) and SSS 
(F) skin. Mild fibrosis and dense, tightly packed and irregularly distributed collagen 
bundles are evident in SSS dermis (F) (original magnification x20). G,H: 
Immunostaining for the panendothelial marker vWF in control (G) and SSS (H) skin 
(blue haematoxylin counterstaining; original magnification x20). 
 
 
Table 1. Quantitative Real-Time PCR results*  
 
 MCP-1 VEGF Endothelin-1 IL-1 TGF- CTGF Col1A2 FGFR-3 IL-6 Fibronectin-1 Thrombospondin-1 
Epidermis 1.03 1.4 0.76 0.05 0.95 1.13 1.05 0.86 0.98 1.5 0.7 
Dermis 0.26 3.31 1.39 0.29 1.4 1.42 11.39 0.18 0.11 4.1 5 
 
*The value in SSS is represented as x-fold increased or decreased versus control 
assumed = 1.    
